510(k) device
LensHooke X1 PRO Semen Quality Analyzer
Bonraybio Co., Ltd. · Semen Analysis Device (POV, Class II) · First FDA decision Nov 16, 2018, newest Oct 28, 2020Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "LensHooke X1 PRO"
MAUDE reports
0
Brand "LensHooke X1 PRO", since 2015
PubMed studies
4
Mentioning "LensHooke X1 PRO"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K202089 · Decided Oct 28, 2020 · 92 days after receipt
Device type: Semen Analysis Device (POV) · Laboratory Medicine & Pathology
K180343 · Decided Nov 16, 2018 · 282 days after receipt
Device type: Semen Analysis Device (POV) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "LensHooke X1 PRO", any status and sponsor, newest update first.
No registered device study names "LensHooke X1 PRO".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LensHooke X1 PRO", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POV
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "LensHooke X1 PRO"[tiab]. The summary above synthesizes these.
- Validation of LensHooke® X1 PRO and Computer-Assisted Semen Analyzer Compared with Laboratory-Based Manual Semen Analysis.
Agarwal A, Panner Selvam MK, Ambar RF · World J Mens Health · 2021
- ICSI/IVF treatments allocation using CASAs compared to manual semen analyses.
Xu M, Zhao M, Yang H, et al. · Medicine (Baltimore) · 2025Comparative Study, Observational Study
- Automation of human semen analysis using a novel artificial intelligence optical microscopic technology.
Agarwal A, Henkel R, Huang CC, et al. · Andrologia · 2019Evaluation Study
- Validation of AI-based semen analysis by urologists in training: clinical impact after varicocelectomy.
Russo GI, Salvaggio A, Asmundo MG · Front Urol · 2025
Other devices of this type
Also filed under product code POV.
- YO Home Sperm TestMedical Electronic Systems , Ltd. · 510(k) 2024
- Seaman Pro/SeamanCheckcells, Inc. · 510(k) 2026
- LensHooke X3 PRO Semen Quality AnalyzerBonraybio Co., Ltd. · 510(k) 2025
- LensHooke X12 PRO Semen Analysis SystemBonraybio Co., Ltd. · 510(k) 2025
- SQA-iOw Sperm Quality AnalyzerMedical Electronic Systems , Ltd. · 510(k) 2025
- SQA-iO Sperm Quality AnalyzerMedical Electronic Systems , Ltd. · 510(k) 2023
- SwimCount Sperm Quality TestMotilitycount Aps · 510(k) 2019
- Trak Plus Male Fertility Testing SystemSandstone Diagnostics, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.